Walmart's New Health Food Push: Is It Too Hard to Swallow?
Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger.gif){kind=logo}
MOST NOTEWORTHY: AstraZeneca, Massey Energy and Freeport McMoRan were today's noteworthy upgrades:
- Dresdner Kleinwort upgraded shares of AstraZeneca (NYSE: AZN) to Buy from Hold following the company's settlement with Ranbaxy on the Nexium patent.
- Massey Energy (NYSE: MEE) was raised to Overweight from Neutral at Massey Energy citing the company's leverage to metallurgical coal prices in 2009.
- Freeport McMoRan (NYSE: FCX) was upgraded at HSBC to Overweight from Neutral on valuation.
OTHER UPGRADES:
- Arcelor Mittal (NYSE: MT) was upgraded to Buy from Hold at Citigroup.
- Merrill upgraded Bernis (NYSE: BMS) to Neutral from Sell.
Goldman Earnings Sink After Buffett Dividend
Johnson & Johnson's Income Falls 23%
Burberry Shares Leap on Sales Update
